53 related articles for article (PubMed ID: 36209368)
1. Integrated multi-omics analyses reveal the TM4SF family genes with prognostic and therapeutic relevance in hepatocellular carcinoma.
Tang Q; Wang S; Li H; Liu J; Hu X; Zhao D; Di M
Aging (Albany NY); 2024 Jan; 16(1):593-616. PubMed ID: 38206300
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms and biomarkers of immune-related adverse events in gastric cancer.
Ding P; Liu P; Meng L; Zhao Q
Eur J Med Res; 2023 Nov; 28(1):492. PubMed ID: 37936161
[TBL] [Abstract][Full Text] [Related]
3. Immune-related gene TM4SF18 could promote the metastasis of gastric cancer cells and predict the prognosis of gastric cancer patients.
Qin X; Chen Y; Ma S; Shen L; Ju S
Mol Oncol; 2022 Dec; 16(22):4043-4059. PubMed ID: 36209368
[TBL] [Abstract][Full Text] [Related]
4. [CircPCSK5 is highly expressed in gastric cancer and promotes cancer cell proliferation, invasion and epithelial-mesenchymal transition].
Zuo X; Cai J; Chen Z; Li Y; Zhang D
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Oct; 42(10):1440-1451. PubMed ID: 36329577
[TBL] [Abstract][Full Text] [Related]
5. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.
Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW
J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461
[TBL] [Abstract][Full Text] [Related]
6. sMicroRNA-28-5p acts as a metastasis suppressor in gastric cancer by targeting Nrf2.
Yue CF; Li LS; Ai L; Deng JK; Guo YM
Exp Cell Res; 2021 May; 402(2):112553. PubMed ID: 33737068
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Tetraspanin31 contributes to malignant potential and poor outcomes in gastric cancer.
Takashima Y; Komatsu S; Ohashi T; Kiuchi J; Kamiya H; Shimizu H; Arita T; Konishi H; Shiozaki A; Kubota T; Okamoto K; Fujiwara H; Tsuda H; Otsuji E
Cancer Sci; 2022 Jun; 113(6):1984-1998. PubMed ID: 35307915
[TBL] [Abstract][Full Text] [Related]
8. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
Jin JJ; Dai FX; Long ZW; Cai H; Liu XW; Zhou Y; Hong Q; Dong QZ; Wang YN; Huang H
Oncol Rep; 2017 Jun; 37(6):3279-3286. PubMed ID: 28440473
[TBL] [Abstract][Full Text] [Related]
9. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
10. Gastric cancer.
Smyth EC; Nilsson M; Grabsch HI; van Grieken NC; Lordick F
Lancet; 2020 Aug; 396(10251):635-648. PubMed ID: 32861308
[TBL] [Abstract][Full Text] [Related]
11. A signature of immune-related gene pairs predicts oncologic outcomes and response to immunotherapy in lung adenocarcinoma.
Xu F; Zhan X; Zheng X; Xu H; Li Y; Huang X; Lin L; Chen Y
Genomics; 2020 Nov; 112(6):4675-4683. PubMed ID: 32798715
[TBL] [Abstract][Full Text] [Related]
12. Identification of gene expression profiles and immune cell infiltration signatures between low and high tumor mutation burden groups in bladder cancer.
Wu Z; Wang M; Liu Q; Liu Y; Zhu K; Chen L; Guo H; Li Y; Shi B
Int J Med Sci; 2020; 17(1):89-96. PubMed ID: 31929742
[TBL] [Abstract][Full Text] [Related]
13. Vestigial like family member 3 is a novel prognostic biomarker for gastric cancer.
Zhang LH; Wang Z; Li LH; Liu YK; Jin LF; Qi XW; Zhang C; Wang T; Hua D
World J Clin Cases; 2019 Aug; 7(15):1954-1963. PubMed ID: 31423427
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
